April 27, 2026
Nervonik
Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.
- Round
- Series B
- Amount raised
- $52.5M
- Lead investor
- Amzak Health Investors
- Industry
- Manufacturing
- Headquarters
- Los Angeles, United States
- Employees
- 11-50
- Website
- nervonik.com
- View profile →
Other investors
- U.S. Venture Partners
Source: Crunchbase snapshot 2026-05-15